| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
58,625,000 |
| Market
Cap: |
1.76(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.72 - $37.28 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
98,505 |
119,208 |
124,343 |
450,780 |
| Total Sell Value |
$3,345,846 |
$3,929,526 |
$4,091,741 |
$15,155,681 |
| Total People Sold |
1 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
10 |
11 |
37 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2022-11-11 |
4 |
AS |
$34.95 |
$237,655 |
D/D |
(6,800) |
1,644 |
|
4% |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2022-11-11 |
4 |
OE |
$9.24 |
$62,832 |
D/D |
6,800 |
8,444 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2022-11-09 |
4 |
AS |
$34.97 |
$24,480 |
D/D |
(700) |
1,644 |
|
7% |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2022-11-09 |
4 |
OE |
$9.24 |
$6,468 |
D/D |
700 |
2,344 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-09-14 |
4 |
OE |
$33.75 |
$46,575 |
D/D |
1,380 |
780,074 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,895 |
781,454 |
|
- |
|
| Martin Tami Tillotson |
Sr. V.P., Regulatory Affairs |
• – – |
2022-08-22 |
4 |
AS |
$35.98 |
$179,900 |
D/D |
(5,000) |
87,220 |
|
6% |
|
| Martin Tami Tillotson |
Sr. V.P., Regulatory Affairs |
• – – |
2022-08-22 |
4 |
OE |
$7.90 |
$39,500 |
D/D |
5,000 |
92,220 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-16 |
4 |
AS |
$34.01 |
$499,651 |
D/D |
(14,690) |
775,559 |
|
5% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-16 |
4 |
OE |
$34.01 |
$312,307 |
D/D |
9,182 |
790,249 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,530 |
799,431 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-15 |
4 |
AS |
$34.03 |
$588,752 |
D/D |
(17,302) |
759,901 |
|
8% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-15 |
4 |
OE |
$34.03 |
$367,945 |
D/D |
10,813 |
777,203 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,575 |
788,016 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-10 |
4 |
AS |
$31.22 |
$887,803 |
D/D |
(28,437) |
741,441 |
|
20% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,900 |
769,878 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-09 |
4 |
AS |
$31.15 |
$1,228,276 |
D/D |
(39,431) |
724,978 |
|
21% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,100 |
764,409 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-08 |
4 |
AS |
$31.40 |
$3,709,403 |
D/D |
(117,907) |
701,309 |
|
15% |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-08-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
192,000 |
819,216 |
|
- |
|
| Martin Tami Tillotson |
Sr. V.P., Regulatory Affairs |
• – – |
2022-08-04 |
4 |
AS |
$32.98 |
$164,900 |
D/D |
(5,000) |
87,220 |
|
8% |
|
| Martin Tami Tillotson |
Sr. V.P., Regulatory Affairs |
• – – |
2022-08-04 |
4 |
OE |
$7.90 |
$39,500 |
D/D |
5,000 |
92,220 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2022-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
1,644 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-03-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,750) |
1,047,700 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2022-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,750 |
627,216 |
|
- |
|
345 Records found
|
|
Page 6 of 14 |
|
|
0.76 (2.59%) 
